Tekmira Pharmaceuticals Corporation (3627)
Market Closed
13 Aug, 06:00
JPX JPX Primary ¥
265. 00
0
0%
¥
3.26B Market Cap
- P/E Ratio
20% Div Yield
12,500 Volume
- Eps
¥ 265
Previous Close Want to track 3627 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tekmira Pharmaceuticals Corporation (3627) Statistics
Valuation metrics
Market Cap 3.26B
Enterprise value 3.15B
Trailing P/E (ttm) -87.42
Forward P/E 7.44
PEG ratio -1.72
Price/Sales (ttm) 0.31
Price/Book (mrq) 0.53
Enterprise Value/Revenue 0.31
Enterprise Value/EBITDA 5.47
Overview
Shares outstanding 12.07M
Float 8.03M
Shares short -
% Held by insiders 0.28%
% Held by institutions 0.08%
Average volume (10 days) 27.44K
Average volume (90 days) 63.92K
Price summary
52-Week low 243
52-Week high 335
Beta 0.62
50-Day moving average 270.26
200-Day moving average 270.97
Dividends and splits
Forward annual dividend rate 20
Forward annual dividend yield 0.0667%
Trailing annual dividend rate 5
Trailing annual dividend yield 0.0189%
5-Year annual dividend yield 1.41%
Payout ratio 0.52
Dividend Date 26 Feb 2026
Ex-Dividend Date 26 Feb 2026
Last split factor 100:1
Last split Date 28 Aug 2013
Financials
Fiscal year
Fiscal year ends 28 Feb 2026
Most recent quarter (mrq) 31 May 2025
Profitability
Profit margin -0%
Operating margin 0.01%
Operational effectiveness
Return on assets -0%
Return on equity -0.01%
Income Statement
Revenue (ttm) 10.41B
Revenue per share (ttm) 851.26
Quarterly revenue growth (yoy) 0.16%
Gross profit (ttm) 3.81B
EBITDA 865.43M
Net income to common (ttm) -58.78M
Diluted EPS (ttm) -3.12
Quarterly earnings growth (yoy) 0.19%
Balance Sheet
Total cash (mrq) 2.88B
Total cash per share (mrq) 235.33
Total debt (mrq) 3.01B
Total Debt/Equity (mrq) 0.47
Current ratio (mrq) 2.38%
Book value per share (mrq) 498.32
Cash Flow
Cash flow statement 386.67M
Levered free cash flow (LFCF) -523.88M
